BioCryst Pharmaceuticals, Inc. (BMV:BCRX)
197.50
-3.50 (-1.74%)
At close: May 23, 2025
BioCryst Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence. Standard template. Financial Sources.